3-Methyl-6-(4-methyl-3-nitrophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-amine

Catalog No. :
ACKJEL904
CAS No. :
1956334-72-7
Molecular Formula :
C13H12N6O2
Molecular Weight :
284.28

IUPAC Name:3-methyl-6-(4-methyl-3-nitrophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-amine

3-Methyl-6-(4-methyl-3-nitrophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$81.00Login to see priceInquiryInquiry
1g97%$217.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Methyl-6-(4-methyl-3-nitrophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-amine
IUPAC Name3-methyl-6-(4-methyl-3-nitrophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-amine
MDL No.MFCD29921192
Molecular FormulaC13H12N6O2
Molecular Weight284.28
SMILESNC1=CC(C2=CC=C(C)C([N+]([O-])=O)=C2)=NN3C1=NN=C3C
InChI KeyUNNWPWZTRKQJAD-UHFFFAOYSA-N
Synonym1,2,4-Triazolo[4,3-b]pyridazin-8-amine, 3-methyl-6-(4-methyl-3-nitrophenyl)-
CAS No.1956334-72-7
PubChem CID118995222

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACKJEL904 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVDUR821 route compound structure diagram
    ACVDUR82180500-27-2 In Stock
  2. Plus
  3. ACFUAG217 route compound structure diagram
    ACFUAG21753085-52-2 In Stock
  4. Then
  5. ACKJEL904 route product structure diagram
    ACKJEL9041956334-72-7
Inquiry

2. ACKJEL904 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZKNR745 route compound structure diagram
    ACZKNR7451072945-06-2 In Stock
  2. Plus
  3. ACFUAG217 route compound structure diagram
    ACFUAG21753085-52-2 In Stock
  4. Then
  5. ACKJEL904 route product structure diagram
    ACKJEL9041956334-72-7
Inquiry

Comments (0)